Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Moved up those "pinks" at the last one minute

The big difference is that Esperion succeeded in hitting their endpoints in...

February 8, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:Moved up those "pinks" at the last one minute

I respectfully disagree. Esperion plan and management have been more or less...

February 8, 2017

T.RVX

RE:RE:RE:RE:RE:Moved up those "pinks" at the last one minute

At the 12/15/16 Corporate Update, they indicated that they still hope to add...

February 7, 2017

T.RVX

RE:RE:RE:RE:A PCSK9 MEETS CV GOALS-A FIRST?

Good afternoon. Glad to chime in. JK wrote: "As I recall DM has said...

February 4, 2017

T.RVX

RE:Eli Lilly (LLY) Scraps Phase III study-Solanezumab-AD

GV, In addition to the Phase 1a trial news release that you shared on the...

February 2, 2017

ESPR

Esperion Completes Enrollment of Phase 3 Long-Term Study

Esperion Completes Enrollment of Pivotal Phase 3 Long-Term Safety and...

January 31, 2017

T.RVX

RE:RE:The company just tweeted this video....

That video has been on the RVX website for almost 5 months now and has been...

January 27, 2017

T.RVX

RE:JUst saw the NR and move....NICE! indeed...

G, It was a small study. 8 health and 8 CKD patients. You can view the full...

January 24, 2017

T.RVX

RE:RE:RE:SAGA OF HDL CONTINUES

F6 nailed it. It's not just about raising HDL cholesterol...it's...

January 17, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Time to get serious about this company

GV, I took a look back on ClinicalTrials.gov for the ASSURE trial. From what...

January 13, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Time to get serious about this company

Toniv and GV, Just to clarify, it doesn't matter if 0.4%, 0.6% or even...

January 13, 2017

ESPR

ESPR Trial Launches and New Releases 1/8/17 and 1/9/17

ESPR announces initiation of three pivotal Phase 3 LDL cholesterol studies...

January 12, 2017

T.RVX

RE:RE:RE:RE:RE:RE:Resverlogix Announces Presentation at 9th Annual Biotech Sho

Very doubtful that it is a misprint. Clayton indicated to me last month that...

January 7, 2017

T.RVX

RE:RE:Public Zenith

Toniv, DM never said that results would be available in 6 to 8 weeks for the...

January 6, 2017

T.RVX

RE:RE:RE:RE:Resverlogix Announces Presentation at 9th Annual Biotech Sho

Most likely this means that they are making the slide deck available online...

January 6, 2017

T.RVX

RE:RE:RE:RE:Zenith webcast

Toniv, DM never said "ZEN-3694 trial results would be available in a...

December 20, 2016

T.RVX

RE:HOPE OUR COMBO WORKS BETTER/ THOUGHTS BEAR

JK, The failure of PLATO emphasizes the need for second-line therapies when...

December 14, 2016

T.RVX

RE:CEO AND INVESTOR CONFER 2017- OF COURSE DM WILL BE THERE

Thanks JK. DM will also be giving a Zenith CEO presentation there too.

December 14, 2016

T.RVX

RE:RE:RE:RE:RE:RE:RE:ASTRAZENECA CUTTING U.S.JOBS/ PATENT EXPIRATIONS/ 208 MIGHT

This is the patent you are referring to. It is for co-treatment with RVX-208...

December 12, 2016

T.RVX

RE:RE:RE:EMPA-REG

Thanks for the info Bfw. BearDownAZ

December 6, 2016